Nu Med Valuation
| NUMD Stock | USD 0.01 0 10.00% |
Nu Med seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Nu Med Plus from analyzing the firm fundamentals such as Current Valuation of 1.63 M, return on asset of -6.62, and Net Income of (830.06 K) as well as examining its technical indicators and probability of bankruptcy. . In general, most investors recommend purchasing undervalued equities and exiting overvalued equities since, at some point future time, asset prices and their ongoing real values will come together.
Overvalued
Today
Please note that Nu Med's price fluctuation is out of control at this time. Calculation of the real value of Nu Med Plus is based on 3 months time horizon. Increasing Nu Med's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the NUMD otc stock is determined by what a typical buyer is willing to pay for full or partial control of Nu Med Plus. Since Nu Med is currently traded on the exchange, buyers and sellers on that exchange determine the market value of NUMD OTC Stock. However, Nu Med's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0126 | Real 0.0121 | Hype 0.01 | Naive 0.008409 |
The real value of NUMD OTC Stock, also known as its intrinsic value, is the underlying worth of Nu Med Plus OTC Stock, which is reflected in its stock price. It is based on Nu Med's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Nu Med's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Nu Med Plus helps investors to forecast how NUMD otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Nu Med more accurately as focusing exclusively on Nu Med's fundamentals will not take into account other important factors: Nu Med Total Value Analysis
Nu Med Plus is now expected to have valuation of 1.63 M with market capitalization of 1.14 M, debt of 2.06 K, and cash on hands of 2.54 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Nu Med fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.63 M | 1.14 M | 2.06 K | 2.54 K |
Nu Med Asset Utilization
One of the ways to look at asset utilization of NUMD is to check how much profit was generated for every dollar of assets it reports. Nu Med Plus owns a negative utilization of current and long term assets of -6.62 %, losing $0.0662 for each dollar of current and long term assets held by the firm. Discouraging asset utilization conveys that the company is being less competent with each dollar of current and long term assets it owns. Strictly speaking, asset utilization of Nu Med Plus shows how wasteful it operates for each dollar spent on its current and long term assets.Nu Med Ownership Allocation
Nu Med Plus secures a total of 81.35 Million outstanding shares. Nu Med Plus owns majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 61.99 % of Nu Med Plus outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company retains, if the real value of the firm is less than the current market value, you may not be able to make money on it.Nu Med Profitability Analysis
Net Loss for the year was (830.06 K) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Nu Med's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Nu Med and how it compares across the competition.
About Nu Med Valuation
The otc valuation mechanism determines Nu Med's current worth on a weekly basis. Our valuation model uses a comparative analysis of Nu Med. We calculate exposure to Nu Med's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Nu Med's related companies.Nu-Med Plus, Inc., a medical device company, engages in the design, development, enhancement, and commercialization of medical devices worldwide. Nu-Med Plus, Inc. was incorporated in 2011 and is headquartered in Salt Lake City, Utah. Nu Med operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 2 people.
8 Steps to conduct Nu Med's Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Nu Med's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Nu Med's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Nu Med's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Nu Med's revenue streams: Identify Nu Med's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Nu Med's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Nu Med's growth potential: Evaluate Nu Med's management, business model, and growth potential.
- Determine Nu Med's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Nu Med's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Nu Med Growth Indicators
Investing in growth stocks can be very risky. If the company such as Nu Med does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 79.3 M | |
| Retained Earnings | -9.6 M | |
| Shares Float | 27.7 M |
Complementary Tools for NUMD OTC Stock analysis
When running Nu Med's price analysis, check to measure Nu Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Med is operating at the current time. Most of Nu Med's value examination focuses on studying past and present price action to predict the probability of Nu Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Med's price. Additionally, you may evaluate how the addition of Nu Med to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |